Sprint Bioscience

ISIN SE0010833178Filings at the FI

At a glance

Most recent filing on April 1, 2019 — a sale by Anders Åberg on Mar 28, 2019.

We hold 1 visible filing, going back to March 28, 2019.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

All 1 shown

  • Anders Åberg Chief executive officer
    147,397 SEKOpen-market sale
    TradedMar 28, 2019FiledApr 1, 2019